Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCastelnau Group Regulatory News (CGL)

Share Price Information for Castelnau Group (CGL)

Share Price is delayed by 15 minutes
Get Live Data
89.50    0.00 (0.00%)
Bid:
88.00
Ask:
91.00
Spread: 3.00 (3.409%)
Market Cap: £298.49m
CGL Live PriceLast checked at - London Stock Exchange

Intraday Castelnau Group Share Chart

Performance Fee Arrangements Update

31 May 2024 07:00

Castelnau Group Ltd - Performance Fee Arrangements Update

Castelnau Group Ltd - Performance Fee Arrangements Update

PR Newswire

LONDON, United Kingdom, May 31

LEI: 213800PED8RFUBMK1T64

31 May 2024

Castelnau Group Limited(β€œCastelnau” or the β€œCompany”)

Performance Fee Arrangements Update

The Board of the Company announces, that as detailed in its Annual Report published on 19 April 2024, it has reviewed the performance fee arrangements under the investment management agreement with Phoenix Asset Management Partners Limited (the β€œInvestment Manager”) dated 23 September 2021 (the β€œIMA”) and have today entered into a restated and amended investment management agreement (the β€œRevised IMA”) which includes a number of minor amendments to the way the performance fee is calculated.

Summary of changes

The Investment Manager does not charge a management fee to Castelnau and is instead incentivised solely via a performance based fee arrangement. In summary, the performance fee arrangement is measured over consecutive periods of not less than three years with first period commencing on the Company’s IPO on 18 October 2021 and ending on 31 December 2024. The performance fee payable is one third of the outperformance of the Net Asset Value total return after adjustment for inflows and outflows, over the FTSE All-Share Total Return Index (the β€œBenchmark”) with, subject to certain regulatory considerations, the performance fee being satisfied through the issuance of new ordinary shares.

The directors believe that the performance fee, measured over a three year period and receivable in shares, remains a significant point of alignment between the Company, its shareholders and the Investment Manager; however, the performance fee arrangement has been reviewed to ensure this alignment is equitable to all parties. Pursuant to the terms of the IMA, the performance fee is paid based on the outperformance over the Benchmark, calculated by reference to the β€˜average’ adjusted net assets of the Company over each performance period. The averaging of the net asset value over the performance period does not fully take into account the outperformance that has been delivered by the Investment Manager and principally for this reason a limited number of adjustments are being made to the IMA, with the revisions summarised below:

The fee will remain as one third of the outperformance over the Benchmark, however, the fee will be calculated by reference to the closing net asset value (β€œClosing NAV”) rather than the average net asset value, and will be compared to the β€˜Benchmark NAV’.The Closing NAV is the reported net asset value of the Company at the period end, excluding any accrued performance fees. This will be compared to the Benchmark NAV, which is the Company’s opening NAV for the performance period to which the Benchmark return is applied. The Benchmark NAV will also be adjusted for the impact of inflows and outflows to the share capital of the Company, to ensure that both the Closing NAV and Benchmark NAV reflect performance adjusted for the impact of these events.

For the avoidance of doubt, no performance fee for the period to 31 December 2024 would currently be payable under either the original or revised performance fee calculation. In addition, no additional changes under the Revised IMA (other than in respect of the performance fee) are being made.

As an SFS company CGL is not required to comply with the provisions of Chapter 11 of the Listing Rules regarding related party transactions. However, the Company have adopted a related party policy which applies to any transaction which it may enter into with any Director, the Manager or any of their affiliates, which would constitute a β€œrelated party transaction” as defined in, and to which would apply, Chapter 11 of the Listing Rules. In accordance with the Company’s related party policy the independent directors of the Company have considered the terms of the Revised IMA and have confirmed that they consider the changes to be fair and reasonable.

Enquiries:

Castelnau GroupRichard Brown - CEOinfo@castelnaugroup.com

Phoenix Asset Management Limited+44 (0) 208 600 0100Gary ChannonSteve TattersGina Bocek

Liberum Capital Limited+44 (0) 20 3100 2000Darren VickersOwen MatthewsWill King

Citigate Dewe Rogerson+44 (0) 20 7638 9571Caroline MerrellToby Moore

Northern Trust International Fund Administration Services (Guernsey) LimitedThe Company SecretaryTrafalgar CourtLes BanquesSt Peter PortGuernseyGY1 3QLTel: 01481 745001

Β 



Date   Source Headline
15th Mar 20135:23 pmRNSAnnual Financial Report
15th Mar 20134:37 pmRNSPrice Monitoring Extension
1st Mar 20132:33 pmRNSTotal Voting Rights
22nd Feb 20132:51 pmRNSHolding(s) in Company
13th Feb 20132:47 pmRNSDirector/PDMR Shareholding
8th Feb 20139:00 amRNSDividend Declaration
8th Feb 20137:00 amRNSAnnual Financial Report
1st Feb 201312:28 pmRNSTotal Voting Rights
2nd Jan 201312:19 pmRNSBlocklisting Interim Review
2nd Jan 201312:17 pmRNSBlocklisting Interim Review
2nd Jan 201312:14 pmRNSTotal Voting Rights
21st Dec 20124:51 pmRNSDirector/PDMR Shareholding
21st Dec 20124:30 pmRNSDirector/PDMR Shareholding
18th Dec 20127:00 amRNSSandy storm estimates
3rd Dec 201212:14 pmRNSTotal Voting Rights
22nd Nov 20128:00 amRNSNew Group Claims Director
22nd Nov 20128:00 amRNSInvestor Day
12th Nov 20127:00 amRNSInterim Management Statement
1st Nov 20124:05 pmRNSTotal Voting Rights
8th Oct 20124:04 pmRNSDirector/PDMR Shareholding
1st Oct 20122:56 pmRNSTotal Voting Rights
25th Sep 201212:00 pmRNSFinancial Calendar
7th Sep 201212:25 pmRNSDirector/PDMR Shareholding
3rd Sep 20122:38 pmRNSTotal Voting Rights
7th Aug 20122:48 pmRNSDirector/PDMR Shareholding
6th Aug 201211:09 amRNSDirector Declaration
6th Aug 20129:59 amRNSDividend Declaration
6th Aug 20127:00 amRNSHalf Yearly Report
1st Aug 201210:49 amRNSTotal Voting Rights
3rd Jul 20127:00 amRNSTotal Voting Rights
2nd Jul 20122:56 pmRNSBlocklisting Interim Review
2nd Jul 20122:54 pmRNSBlocklisting Interim Review
28th Jun 20124:31 pmRNSDirector/PDMR Shareholding
7th Jun 20122:12 pmRNSDirector/PDMR Shareholding
1st Jun 201210:52 amRNSTotal Voting Rights
11th May 20127:00 amRNSInterim Management Statement
1st May 20124:03 pmRNSTotal Voting Rights
12th Apr 201212:08 pmRNSHolding(s) in Company
10th Apr 201212:21 pmRNSAnnual Information Update
2nd Apr 20124:23 pmRNSDirector/PDMR Shareholding
2nd Apr 20124:21 pmRNSTotal Voting Rights
16th Mar 20122:28 pmRNSAnnual Financial Report
13th Mar 20122:29 pmRNSDirector/PDMR Shareholding
1st Mar 20124:19 pmRNSTotal Voting Rights
21st Feb 20123:00 pmRNSDirector/PDMR Shareholding
16th Feb 20124:21 pmRNSDirector/PDMR Shareholding
15th Feb 20125:15 pmRNSDirector/PDMR Shareholding
13th Feb 20123:09 pmRNSDirector/PDMR Shareholding
13th Feb 20123:03 pmRNSDirector/PDMR Shareholding
9th Feb 20129:00 amRNSDividend Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.